July 2021 FDA Recall Drug by Custopharm, Inc.
D-0765-2021 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Custopharm, Inc. on July 30, 2021 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0765-2021

Reason for Recall
Lack of Assurance of Sterility: the manufacturing firm had microbial recoveries during environmental monitoring in aseptic areas of manufacturing.
Initiated
07-30-2021
Reported
09-01-2021
Quantity
19,384 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Distributed Nationwide in the USA
FLUDARABINE PHOSPHATE FOR INJECTION, USP, 50 mg per vial, Single dose vial, Rx Only, Mfd for: Leucadia Pharmaceuticals Carlsbad, CA 92011 U.S.A, NDC 24201-237-01

Batch or Lot Expiration Information

Lot# 31327913C, Exp. Date 10/2022